TG Therapeutics
Scott Stansell, RN, BSN, currently serves as the Associate Director and Access & Reimbursement Manager at TG Therapeutics, Inc., since August 2022. With extensive experience in the pharmaceutical industry, Stansell has held various leadership roles, including Associate Director for Horizon, where responsibilities included managing patient access to therapy for rare diseases in multiple states. Prior positions include Infusion Support Manager at Sanofi Genzyme, where Stansell facilitated patient enrollment for Multiple Sclerosis treatments, and roles at Pfizer and Mallinckrodt Pharmaceuticals, achieving notable regional rankings. Stansell’s career also includes significant contributions to Biogen Idec, Elan, and PsychNet Systems, demonstrating a strong record in sales, patient education, and healthcare system collaboration. Stansell holds a BSN in Nursing and a BS in Biology from The University of Alabama.
This person is not in any teams
This person is not in any offices
TG Therapeutics
2 followers
TG Therapeutics is a fully-integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.